Literature DB >> 1916500

Detection of Helicobacter pylori infection of the gastric mucosa by measurement of gastric aspirate ammonium and urea concentrations.

W D Neithercut1, A Milne, R S Chittajallu, A M el Nujumi, K E McColl.   

Abstract

Helicobacter pylori possesses unusually high urease activity that lowers the urea concentration and raises the ammonium concentration of the gastric juice in infected people. The value of measuring urea and ammonium concentrations in gastric juice obtained during upper gastrointestinal endoscopy as a means of diagnosing the presence and eradication of the infection was assessed. Twenty four subjects with the infection and 14 in whom it had been eradicated were examined. Their H pylori status was confirmed by antral biopsy and 14C urea breath test. The median (range) gastric juice urea concentration in infected subjects was 0.8 mmol/l (0.5-2.9 mmol/l), which was lower than that in the uninfected subjects (2.1 mmol/l (1.0-3.7 mmol/l)) (p less than 0.001). The median gastric juice ammonium concentration in infected subjects was 3.4 mmol/l (1.0-13.0 mmol/l), which was higher than that in the uninfected subjects (0.64 mmol/l (0.02-1.4 mmol/l)) (p less than 0.001). Though the two groups overlapped in respect of their urea and ammonium concentrations, they were completely different when the urea: ammonium ratios were calculated--the ratios ranged from 0.04-0.7 (median 0.26) and from 1.1-113 (median 3.4) in infected and uninfected subjects respectively (p less than 0.001). Treatment with H2 antagonists did not change the concentrations of urea and ammonium or their ratio in gastric juice. Measurement of the urea: ammonium ratio in aspirated gastric juice obtained during routine upper gastrointestinal endoscopy may provide a rapid method of detecting H pylori infection and of confirming its eradication.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916500      PMCID: PMC1379031          DOI: 10.1136/gut.32.9.973

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  10 in total

1.  Azotemia and gastric acidity: the effect of intravenous urea on gastric acid and gastric ammonium production in man.

Authors:  S M MOSSBERG; W R THAYER; H M SPIRO
Journal:  J Lab Clin Med       Date:  1963-03

2.  Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.

Authors:  B J Marshall; C S Goodwin; J R Warren; R Murray; E D Blincow; S J Blackbourn; M Phillips; T E Waters; C R Sanderson
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

3.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

4.  Carbon-14 urea breath test for the diagnosis of Campylobacter pylori associated gastritis.

Authors:  B J Marshall; I Surveyor
Journal:  J Nucl Med       Date:  1988-01       Impact factor: 10.057

5.  14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach.

Authors:  G D Bell; J Weil; G Harrison; A Morden; P H Jones; P W Gant; J E Trowell; A K Yoong; T K Daneshmend; R F Logan
Journal:  Lancet       Date:  1987-06-13       Impact factor: 79.321

6.  The urease enzymes of Campylobacter pylori and a related bacterium.

Authors:  R L Ferrero; S L Hazell; A Lee
Journal:  J Med Microbiol       Date:  1988-09       Impact factor: 2.472

7.  Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.

Authors:  B J Marshall; J R Warren; G J Francis; S R Langton; C S Goodwin; E D Blincow
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

8.  Campylobacter pylori detected noninvasively by the 13C-urea breath test.

Authors:  D Y Graham; P D Klein; D J Evans; D G Evans; L C Alpert; A R Opekun; T W Boutton
Journal:  Lancet       Date:  1987-05-23       Impact factor: 79.321

9.  Characterization of urease from Campylobacter pylori.

Authors:  H L Mobley; M J Cortesia; L E Rosenthal; B D Jones
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

10.  Effect of increasing Helicobacter pylori ammonia production by urea infusion on plasma gastrin concentrations.

Authors:  R S Chittajallu; W D Neithercut; A M Macdonald; K E McColl
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

  10 in total
  15 in total

1.  Significance of blood urea: gastric ammonia gradient for H. pylori detection in childhood.

Authors:  Alexander A Nijevitch; Valentine V Loguinovskaya
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

2.  The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients.

Authors:  K E McColl; A el-Nujumi; L Murray; E el-Omar; D Gillen; A Dickson; A Kelman; T E Hilditch
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

3.  Ammonia as an accelerator of tumor necrosis factor alpha-induced apoptosis of gastric epithelial cells in Helicobacter pylori infection.

Authors:  M Igarashi; Y Kitada; H Yoshiyama; A Takagi; T Miwa; Y Koga
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Quantitative study of Helicobacter pylori in gastric mucus by competitive PCR using synthetic DNA fragments.

Authors:  T Furuta; E Kaneko; M Suzuki; H Arai; H Futami
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

5.  The effect of intragastric ammonia production on titratable gastric acid output in Helicobacter pylori-infected patients with chronic gastritis.

Authors:  Bogdan Cylwik; Jan W Dlugosz; Andrzej Kemona; Maciej Szmitkowski
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

6.  Effect of Helicobacter pylori infection on intragastric urea and ammonium concentrations in patients with chronic renal failure.

Authors:  W D Neithercut; P A Rowe; A M el Nujumi; S Dahill; K E McColl
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

7.  Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer.

Authors:  K E McColl; A el-Nujumi; L S Murray; E M el-Omar; A Dickson; A W Kelman; T E Hilditch
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

8.  Role of ammonia in the pathogenesis of the gastritis, hypergastrinaemia, and hyperpepsinogenaemia I caused by Helicobacter pylori infection.

Authors:  A M el Nujumi; P A Rowe; S Dahill; C A Dorrian; W D Neithercut; K E McColl
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

9.  Ammonia inhibits proliferation and cell cycle progression at S-phase in human gastric cells.

Authors:  T Matsui; Y Matsukawa; T Sakai; K Nakamura; A Aoike; K Kawai
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

10.  Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.

Authors:  M Suzuki; S Miura; M Mori; A Kai; H Suzuki; D Fukumura; M Suematsu; M Tsuchiya
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.